Pediatric Device Off-Label Use Ramifications Explored At IoM Meeting
This article was originally published in The Gray Sheet
Executive Summary
The impact of off-label use of devices and drugs on adverse event trends will be explored in a whitepaper slated for release later this year
You may also be interested in...
MCAC To Scrutinize Home Sleep Tests; Negative Tech Assessment Released
The effectiveness of unattended portable multi-channel home sleep test devices as an alternative to facility-based obstructive sleep apnea diagnosis (OSA) will be evaluated at an upcoming Medicare Coverage Advisory Committee meeting
MCAC To Scrutinize Home Sleep Tests; Negative Tech Assessment Released
The effectiveness of unattended portable multi-channel home sleep test devices as an alternative to facility-based obstructive sleep apnea diagnosis (OSA) will be evaluated at an upcoming Medicare Coverage Advisory Committee meeting
Pediatric Devices Lack Clear Adverse Event Communication Channels
Gaps in adverse event reporting processes emerged as a key concern during Aug. 31 public testimony for the Institute of Medicine's Committee on Postmarket Surveillance of Pediatric Medical Devices